State ID
Clinical Trials in Idaho
Recruiting clinical trials with at least one study location in Idaho. Data updated daily from ClinicalTrials.gov.
Top Conditions in Idaho
Lung Non-Small Cell Carcinoma (2)Stage II Lung Cancer AJCC v8 (2)Stage IIIA Lung Cancer AJCC v8 (2)Stage IIIB Lung Cancer AJCC v8 (2)Idiopathic Short Stature (2)Anatomic Stage IV Breast Cancer AJCC v8 (2)Atopic Dermatitis (2)Breast Cancer (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)
Frequently Asked Questions — Clinical Trials in Idaho
How many clinical trials are currently recruiting in Idaho?
ClinicalMetric currently tracks 50 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 50. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Idaho?
Idaho hosts clinical trials across a broad range of medical conditions, including Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Idaho?
To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Idaho
NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06346392 Phase 3
Recruiting
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Seco...
Condition
Gastric Cancer
Enrollment
572 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
NCT06309979 N/A
Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
Condition
Idiopathic Short Stature
Enrollment
300 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT06797518 Phase 2
Recruiting
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kid...
Condition
Glomerulonephritis, IGA
Enrollment
20 pts
Location
United States, Argentina, Israel
Sponsor
Novartis Pharmaceuticals
NCT06827262 N/A
Recruiting
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Condition
Chronic Low-back Pain
Enrollment
1,500 pts
Location
United States
Sponsor
Boston Scientific Corporation
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06439277 Phase 3
Recruiting
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidit...
Condition
Obesity
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT05647265 Phase 2
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...
Condition
Pleural Biphasic Mesothelioma
Enrollment
26 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06269705 Phase 3
Recruiting
ZILRETTA in Subjects With Shoulder Osteoarthritis
Condition
Glenohumeral Osteoarthritis
Enrollment
150 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
NCT06338995 Phase 3
Recruiting
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis ...
Condition
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Enrollment
510 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06382155 Phase 2
Recruiting
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Condition
Idiopathic Short Stature
Enrollment
100 pts
Location
United States, Australia, France
Sponsor
BioMarin Pharmaceutical
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT07266402 Phase 3
Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus...
Condition
Chronic Inducible Urticaria
Enrollment
240 pts
Location
United States, Germany, Lithuania
Sponsor
Celldex Therapeutics
NCT06793215 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus...
Condition
Non-Small Cell Lung Cancer
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT05918523 N/A
Recruiting
A Long-Term Follow-Up Study of Participants Exposed to REACT
Condition
Diabetic Kidney Disease
Enrollment
80 pts
Location
United States
Sponsor
Prokidney
NCT07133308 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With ...
Condition
Alopecia Areata
Enrollment
355 pts
Location
United States, Canada
Sponsor
Sun Pharmaceutical Industries,
NCT06112613 N/A
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
410 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
Page 1 of 2 — 50 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology